- Home
- RVPH vs SFWL Comparison
RVPH vs SFWL Comparison
Compare RVPH & SFWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- SFWL
- Stock Information
- Founded
- RVPH 2006
- SFWL 2001
- Country
- RVPH United States
- SFWL China
- Employees
- RVPH N/A
- SFWL N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- SFWL Trucking Freight/Courier Services
- Sector
- RVPH Health Care
- SFWL Industrials
- Exchange
- RVPH Nasdaq
- SFWL Nasdaq
- Market Cap
- RVPH 32.8M
- SFWL 79.1M
- IPO Year
- RVPH N/A
- SFWL 2023
- Fundamental
- Price
- RVPH $0.39
- SFWL $0.98
- Analyst Decision
- RVPH Strong Buy
- SFWL
- Analyst Count
- RVPH 5
- SFWL 0
- Target Price
- RVPH $9.00
- SFWL N/A
- AVG Volume (30 Days)
- RVPH 3.7M
- SFWL 10.6K
- Earning Date
- RVPH 08-13-2025
- SFWL 09-04-2025
- Dividend Yield
- RVPH N/A
- SFWL N/A
- EPS Growth
- RVPH N/A
- SFWL 4.79
- EPS
- RVPH N/A
- SFWL 0.13
- Revenue
- RVPH N/A
- SFWL $504,158,000.00
- Revenue This Year
- RVPH N/A
- SFWL N/A
- Revenue Next Year
- RVPH N/A
- SFWL N/A
- P/E Ratio
- RVPH N/A
- SFWL $7.47
- Revenue Growth
- RVPH N/A
- SFWL 24.75
- 52 Week Low
- RVPH $0.30
- SFWL $0.86
- 52 Week High
- RVPH $4.28
- SFWL $1.60
- Technical
- Relative Strength Index (RSI)
- RVPH 35.22
- SFWL 50.09
- Support Level
- RVPH $0.38
- SFWL $0.95
- Resistance Level
- RVPH $0.45
- SFWL $1.02
- Average True Range (ATR)
- RVPH 0.05
- SFWL 0.05
- MACD
- RVPH 0.01
- SFWL 0.00
- Stochastic Oscillator
- RVPH 17.57
- SFWL 67.85
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About SFWL Shengfeng Development Limited
Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services.